GSK-204678

Study Sponsor: GSK

Study Title

A single centre, open-label, parallel-group, single oral dose study to evaluate the pharmacokinetics, safety and tolerability of Pyrimethamine in healthy Japanese and Caucasian male subjects

Medicine or Vaccine (generic name)

pyrimethamine

Sponsor Identification Number

204678

Trial Registry Identification Number(#'s)

NCT03258762

Medical Condition

Toxoplasmosis

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=204678

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03258762

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format.

Date Added to this Site

February 2020